Verseon Corporation Transaction in Own Shares and Total Voting Rights (2391H)
June 06 2017 - 2:15AM
UK Regulatory
TIDMVSN
RNS Number : 2391H
Verseon Corporation
06 June 2017
June 6, 2017
Verseon Corporation
("Verseon" or the "Company")
Transaction in Own Shares and Total Voting Rights
FREMONT, Calif.-Verseon, a technology-based pharmaceutical
company, announces that on June 5, 2017 the Company purchased
42,917 Common Shares in the Company (the "Shares") for an aggregate
price of $10,729.25 (the "Transaction") from former option holders
in accordance with the terms and conditions of the Company's 2007
Option Plan (the "2007 Plan"). Following the Transaction, the
Shares will be held in treasury.
Pursuant to the 2007 Plan, during their services to the Company,
option holders may elect to exercise options prior to their full
vesting, with the Company retaining the right to repurchase any
unvested shares at the original purchase price at the completion of
the option holders' service.
Total Voting Rights
Following the Transaction, the issued share capital of the
Company will consist of 151,452,891 Common Shares and the Company
will hold 42,917 shares in treasury. Therefore, the total number of
Common Shares in the Company with voting rights will be
151,409,974. This figure may be used by shareholders in the Company
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change in their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
For further information, please contact
Verseon Corporation www.verseon.com
+1 (510) 225
Tina Schlafly 9000
Cenkos Securities (NOMAD and
Joint Broker)
+44 (0) 20
Neil McDonald / Beth McKiernan 7397 8900
Cantor Fitzgerald Europe (Joint
Broker)
Marc Milmo / Phil Davies / +44 (0) 20
Callum Butterfield 7894 7000
Mirabaud Securities LLP (Joint
Broker)
+44 (0) 20
Peter Krens 7321 2508
For financial and business media enquiries, please contact
Buchanan Communications Ltd
(PR Advisers)
Henry Harrison-Topham / Jamie +44 (0) 20
Hooper 7466 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737
Simon Vane Percy 821 890
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUGUWUQUPMUMQ
(END) Dow Jones Newswires
June 06, 2017 03:15 ET (07:15 GMT)
Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2024 to May 2024
Verseon (LSE:VSN)
Historical Stock Chart
From May 2023 to May 2024